Logo image of KIN.BR

KINEPOLIS (KIN.BR) Stock Fundamental Analysis

EBR:KIN - Euronext Brussels - BE0974274061 - Common Stock - Currency: EUR

33.4  +0.65 (+1.98%)

Fundamental Rating

4

We assign a fundamental rating of 4 out of 10 to KIN. KIN was compared to 46 industry peers in the Entertainment industry. There are concerns on the financial health of KIN while its profitability can be described as average. KIN is not valued too expensively and it also shows a decent growth rate.


Dividend Valuation Growth Profitability Health

5

1. Profitability

1.1 Basic Checks

KIN had positive earnings in the past year.
In the past year KIN had a positive cash flow from operations.
In multiple years KIN reported negative net income over the last 5 years.
KIN had a positive operating cash flow in 4 of the past 5 years.
KIN.BR Yearly Net Income VS EBIT VS OCF VS FCFKIN.BR Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 0 50M -50M 100M 150M

1.2 Ratios

With a decent Return On Assets value of 3.20%, KIN is doing good in the industry, outperforming 69.57% of the companies in the same industry.
With a decent Return On Equity value of 19.41%, KIN is doing good in the industry, outperforming 78.26% of the companies in the same industry.
With a decent Return On Invested Capital value of 6.48%, KIN is doing good in the industry, outperforming 76.09% of the companies in the same industry.
Industry RankSector Rank
ROA 3.2%
ROE 19.41%
ROIC 6.48%
ROA(3y)N/A
ROA(5y)N/A
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
KIN.BR Yearly ROA, ROE, ROICKIN.BR Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2015 2016 2017 2018 2019 2020 2021 2022 2023 0 20 -20 -40

1.3 Margins

With a decent Profit Margin value of 6.29%, KIN is doing good in the industry, outperforming 69.57% of the companies in the same industry.
In the last couple of years the Profit Margin of KIN has remained more or less at the same level.
With an excellent Operating Margin value of 13.74%, KIN belongs to the best of the industry, outperforming 82.61% of the companies in the same industry.
KIN's Operating Margin has been stable in the last couple of years.
The Gross Margin of KIN (23.56%) is worse than 84.78% of its industry peers.
KIN's Gross Margin has been stable in the last couple of years.
Industry RankSector Rank
OM 13.74%
PM (TTM) 6.29%
GM 23.56%
OM growth 3YN/A
OM growth 5Y0.72%
PM growth 3YN/A
PM growth 5Y-1.43%
GM growth 3YN/A
GM growth 5Y-0.65%
KIN.BR Yearly Profit, Operating, Gross MarginsKIN.BR Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2015 2016 2017 2018 2019 2020 2021 2022 2023 0 20 -20 -40

2

2. Health

2.1 Basic Checks

With a Return on Invested Capital (ROIC) below the Cost of Capital (WACC), KIN is destroying value.
There is no outstanding debt for KIN. This means it has a Debt/Equity and Debt/FCF ratio of 0 and it is amongst the best of the sector and industry.
KIN.BR Yearly Shares OutstandingKIN.BR Yearly Shares OutstandingYearly Shares Outstanding 2016 2017 2018 2019 2020 2021 2022 5M 10M 15M 20M 25M
KIN.BR Yearly Total Debt VS Total AssetsKIN.BR Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2016 2017 2018 2019 2020 2021 2022 200M 400M 600M 800M 1B

2.2 Solvency

KIN has an Altman-Z score of 1.43. This is a bad value and indicates that KIN is not financially healthy and even has some risk of bankruptcy.
KIN has a better Altman-Z score (1.43) than 65.22% of its industry peers.
KIN has a debt to FCF ratio of 7.71. This is a slightly negative value and a sign of low solvency as KIN would need 7.71 years to pay back of all of its debts.
The Debt to FCF ratio of KIN (7.71) is better than 60.87% of its industry peers.
A Debt/Equity ratio of 3.70 is on the high side and indicates that KIN has dependencies on debt financing.
With a Debt to Equity ratio value of 3.70, KIN is not doing good in the industry: 65.22% of the companies in the same industry are doing better.
Industry RankSector Rank
Debt/Equity 3.7
Debt/FCF 7.71
Altman-Z 1.43
ROIC/WACC0.97
WACC6.69%
KIN.BR Yearly LT Debt VS Equity VS FCFKIN.BR Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 0 200M 400M 600M 800M

2.3 Liquidity

A Current Ratio of 0.46 indicates that KIN may have some problems paying its short term obligations.
With a Current ratio value of 0.46, KIN is not doing good in the industry: 78.26% of the companies in the same industry are doing better.
KIN has a Quick Ratio of 0.46. This is a bad value and indicates that KIN is not financially healthy enough and could expect problems in meeting its short term obligations.
KIN's Quick ratio of 0.43 is on the low side compared to the rest of the industry. KIN is outperformed by 78.26% of its industry peers.
Industry RankSector Rank
Current Ratio 0.46
Quick Ratio 0.43
KIN.BR Yearly Current Assets VS Current LiabilitesKIN.BR Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2016 2017 2018 2019 2020 2021 2022 50M 100M 150M 200M

4

3. Growth

3.1 Past

The earnings per share for KIN have decreased strongly by -11.42% in the last year.
Measured over the past 5 years, KIN shows a small growth in Earnings Per Share. The EPS has been growing by 3.01% on average per year.
The Revenue has been growing slightly by 1.05% in the past year.
The Revenue has been growing slightly by 4.93% on average over the past years.
EPS 1Y (TTM)-11.42%
EPS 3YN/A
EPS 5Y3.01%
EPS Q2Q%-99.42%
Revenue 1Y (TTM)1.05%
Revenue growth 3Y50.88%
Revenue growth 5Y4.93%
Sales Q2Q%-14.89%

3.2 Future

The Earnings Per Share is expected to grow by 17.04% on average over the next years. This is quite good.
KIN is expected to show a small growth in Revenue. In the coming years, the Revenue will grow by 2.15% yearly.
EPS Next Y-18.47%
EPS Next 2Y10.07%
EPS Next 3Y12.19%
EPS Next 5Y17.04%
Revenue Next Year-4.56%
Revenue Next 2Y1.75%
Revenue Next 3Y3.09%
Revenue Next 5Y2.15%

3.3 Evolution

When comparing the EPS growth rate of the last years to the growth rate of the upcoming years, we see that the growth is accelerating.
The Revenue growth rate is decreasing: in the next years the growth will be less than in the last years.
KIN.BR Yearly Revenue VS EstimatesKIN.BR Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2014 2016 2018 2020 2022 2024 2026 2028 2030 2032 200M 400M 600M
KIN.BR Yearly EPS VS EstimatesKIN.BR Yearly EPS VS EstimatesYearly EPS VS Estimates 2014 2016 2018 2020 2022 2024 2026 2028 2030 2032 0 2 -2

5

4. Valuation

4.1 Price/Earnings Ratio

A Price/Earnings ratio of 26.30 indicates a quite expensive valuation of KIN.
Based on the Price/Earnings ratio, KIN is valued a bit cheaper than 78.26% of the companies in the same industry.
When comparing the Price/Earnings ratio of KIN to the average of the S&P500 Index (29.35), we can say KIN is valued inline with the index average.
With a Price/Forward Earnings ratio of 13.41, KIN is valued correctly.
Compared to the rest of the industry, the Price/Forward Earnings ratio of KIN indicates a rather cheap valuation: KIN is cheaper than 80.43% of the companies listed in the same industry.
KIN's Price/Forward Earnings ratio indicates a valuation a bit cheaper than the S&P500 average which is at 22.10.
Industry RankSector Rank
PE 26.3
Fwd PE 13.41
KIN.BR Price Earnings VS Forward Price EarningsKIN.BR Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 10 20 30

4.2 Price Multiples

KIN's Enterprise Value to EBITDA is on the same level as the industry average.
Based on the Price/Free Cash Flow ratio, KIN is valued cheaper than 80.43% of the companies in the same industry.
Industry RankSector Rank
P/FCF 8.82
EV/EBITDA 10.41
KIN.BR Per share dataKIN.BR EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 5 10 15 20

4.3 Compensation for Growth

KIN's earnings are expected to grow with 12.19% in the coming years. This may justify a more expensive valuation.
PEG (NY)N/A
PEG (5Y)8.72
EPS Next 2Y10.07%
EPS Next 3Y12.19%

4

5. Dividend

5.1 Amount

KIN has a Yearly Dividend Yield of 1.18%.
KIN's Dividend Yield is rather good when compared to the industry average which is at 2.78. KIN pays more dividend than 82.61% of the companies in the same industry.
With a Dividend Yield of 1.18, KIN pays less dividend than the S&P500 average, which is at 2.33.
Industry RankSector Rank
Dividend Yield 1.18%

5.2 History

The dividend of KIN is nicely growing with an annual growth rate of 20.78%!
Dividend Growth(5Y)20.78%
Div Incr Years1
Div Non Decr Years1
KIN.BR Yearly Dividends per shareKIN.BR Yearly Dividends per shareYearly Dividends per share 2019 2020 2023 2024 2025 0.2 0.4 0.6 0.8

5.3 Sustainability

41.54% of the earnings are spent on dividend by KIN. This is a bit on the high side, but may be sustainable.
The dividend of KIN is growing, but the earnings are growing slower. This means the dividend growth is not sustainable.
DP41.54%
EPS Next 2Y10.07%
EPS Next 3Y12.19%
KIN.BR Yearly Income VS Free CF VS DividendKIN.BR Yearly Income VS Free CF VS DividendYearly Income VS Free CF VS Dividend 2015 2016 2017 2018 2019 2020 2021 2022 2023 0 50M -50M 100M
KIN.BR Dividend Payout.KIN.BR Dividend Payout, showing the Payout Ratio.KIN.BR Dividend Payout.PayoutRetained Earnings

KINEPOLIS

EBR:KIN (3/7/2025, 7:00:00 PM)

33.4

+0.65 (+1.98%)

Chartmill FA Rating
GICS SectorCommunication Services
GICS IndustryGroupMedia & Entertainment
GICS IndustryEntertainment
Earnings (Last)02-20 2025-02-20/amc
Earnings (Next)08-21 2025-08-21
Inst Owners19.91%
Inst Owner ChangeN/A
Ins Owners1.8%
Ins Owner ChangeN/A
Market Cap914.16M
Analysts86
Price Target51.68 (54.73%)
Short Float %N/A
Short RatioN/A
Dividend
Industry RankSector Rank
Dividend Yield 1.18%
Yearly Dividend0.92
Dividend Growth(5Y)20.78%
DP41.54%
Div Incr Years1
Div Non Decr Years1
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)-2.12%
PT rev (3m)-3.71%
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)0%
EPS NY rev (3m)-12.63%
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)-0.6%
Revenue NY rev (3m)-3.39%
Valuation
Industry RankSector Rank
PE 26.3
Fwd PE 13.41
P/S 1.62
P/FCF 8.82
P/OCF 6.51
P/B 5.01
P/tB N/A
EV/EBITDA 10.41
EPS(TTM)1.27
EY3.8%
EPS(NY)2.49
Fwd EY7.46%
FCF(TTM)3.79
FCFY11.34%
OCF(TTM)5.13
OCFY15.36%
SpS20.57
BVpS6.67
TBVpS-0.16
PEG (NY)N/A
PEG (5Y)8.72
Profitability
Industry RankSector Rank
ROA 3.2%
ROE 19.41%
ROCE 8.81%
ROIC 6.48%
ROICexc 6.85%
ROICexgc 8.83%
OM 13.74%
PM (TTM) 6.29%
GM 23.56%
FCFM 18.41%
ROA(3y)N/A
ROA(5y)N/A
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexcg growth 3YN/A
ROICexcg growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5Y0.72%
PM growth 3YN/A
PM growth 5Y-1.43%
GM growth 3YN/A
GM growth 5Y-0.65%
F-Score7
Asset Turnover0.51
Health
Industry RankSector Rank
Debt/Equity 3.7
Debt/FCF 7.71
Debt/EBITDA 4.22
Cap/Depr 44.37%
Cap/Sales 6.53%
Interest Coverage 3.01
Cash Conversion 87.68%
Profit Quality 292.73%
Current Ratio 0.46
Quick Ratio 0.43
Altman-Z 1.43
F-Score7
WACC6.69%
ROIC/WACC0.97
Cap/Depr(3y)32.78%
Cap/Depr(5y)48.64%
Cap/Sales(3y)5.97%
Cap/Sales(5y)10.99%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-11.42%
EPS 3YN/A
EPS 5Y3.01%
EPS Q2Q%-99.42%
EPS Next Y-18.47%
EPS Next 2Y10.07%
EPS Next 3Y12.19%
EPS Next 5Y17.04%
Revenue 1Y (TTM)1.05%
Revenue growth 3Y50.88%
Revenue growth 5Y4.93%
Sales Q2Q%-14.89%
Revenue Next Year-4.56%
Revenue Next 2Y1.75%
Revenue Next 3Y3.09%
Revenue Next 5Y2.15%
EBIT growth 1Y-6.93%
EBIT growth 3YN/A
EBIT growth 5Y5.69%
EBIT Next Year81.02%
EBIT Next 3Y30.65%
EBIT Next 5Y25.76%
FCF growth 1Y-22.26%
FCF growth 3YN/A
FCF growth 5Y31.8%
OCF growth 1Y-6.25%
OCF growth 3YN/A
OCF growth 5Y11.17%